Danish women encouraged to participate in improved cervical cancer screening trials

Lise Lotte Klausholm Bodi long postponed getting a cervical smear test, ignoring invitations she received for screening. She feared the potential diagnosis and thought that if she didn’t get tested, she likely had nothing to worry about. However, six years ago, a conversation with a colleague changed her perspective, and she eventually agreed to the test.

When the results revealed moderate cellular changes and high-risk HPV, she felt a wave of fear wash over her. Now 48 and living in Kolding, Bodi is among over 420,000 Danish women participating annually in cervical cancer screening. The Danish Health Authority has begun recommending that smears for women aged 30 to 59 be analyzed using a more sensitive HPV test, which can detect more cases of the virus and precancerous changes.

While this advancement means better detection, it may also lead to overdiagnosis, according to John Brodersen, a professor of general medicine at the University of Copenhagen. He warns that while some cellular changes could indicate precancerous stages, most resolve without intervention, possibly leading to unnecessary anxiety for many women.

HPV, or human papillomavirus, includes over 100 types, some of which can lead to cervical cancer. Most sexually active individuals will encounter HPV at some point, though many infections resolve on their own. Vaccination before sexual debut can prevent 90% of the virus types responsible for genital warts and cervical cancer.

After several years of close monitoring, Bodi received good news last year: she no longer tested positive for high-risk HPV. Reflecting on her journey, she acknowledges that many of her worries were unwarranted and emphasizes the importance of sharing positive stories about cervical changes to alleviate fear surrounding screenings. Ultimately, she believes screening is essential, citing her father’s experience with prostate cancer as a strong reason for proactive health checks.